中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/07/05 | 6,127 | 6,211 | 6,122 | 6,200 | +100 | +1.6% | 2,170,700 |
| 2024/07/04 | 6,047 | 6,129 | 5,984 | 6,100 | +117 | +2% | 3,713,800 |
| 2024/07/03 | 5,850 | 6,023 | 5,836 | 5,983 | +197 | +3.4% | 3,123,600 |
| 2024/07/02 | 5,644 | 5,830 | 5,625 | 5,786 | +138 | +2.4% | 2,607,100 |
| 2024/07/01 | 5,600 | 5,685 | 5,548 | 5,648 | -68 | -1.2% | 2,732,000 |
| 2024/06/28 | 5,846 | 5,849 | 5,671 | 5,716 | -83 | -1.4% | 3,559,400 |
| 2024/06/27 | 5,772 | 5,839 | 5,750 | 5,799 | -13 | -0.2% | 2,874,200 |
| 2024/06/26 | 5,693 | 5,819 | 5,653 | 5,812 | +175 | +3.1% | 4,690,700 |
| 2024/06/25 | 5,438 | 5,637 | 5,420 | 5,637 | +279 | +5.2% | 3,875,900 |
| 2024/06/24 | 5,200 | 5,359 | 5,191 | 5,358 | +201 | +3.9% | 3,263,600 |
| 2024/06/21 | 5,100 | 5,167 | 5,087 | 5,157 | +15 | +0.3% | 2,537,000 |
| 2024/06/20 | 5,132 | 5,192 | 5,064 | 5,142 | -11 | -0.2% | 1,703,100 |
| 2024/06/19 | 5,106 | 5,162 | 5,050 | 5,153 | +104 | +2.1% | 2,556,200 |
| 2024/06/18 | 4,950 | 5,049 | 4,943 | 5,049 | +107 | +2.2% | 1,888,200 |
| 2024/06/17 | 4,960 | 4,969 | 4,867 | 4,942 | -11 | -0.2% | 2,047,000 |
| 2024/06/14 | 4,986 | 5,017 | 4,876 | 4,953 | -42 | -0.8% | 3,875,500 |
| 2024/06/13 | 5,036 | 5,037 | 4,931 | 4,995 | +29 | +0.6% | 1,900,200 |
| 2024/06/12 | 4,940 | 4,974 | 4,913 | 4,966 | -12 | -0.2% | 2,459,900 |
| 2024/06/11 | 4,811 | 4,978 | 4,811 | 4,978 | +167 | +3.5% | 2,137,800 |
| 2024/06/10 | 4,761 | 4,845 | 4,756 | 4,811 | +54 | +1.1% | 1,117,700 |
| 2024/06/07 | 4,777 | 4,802 | 4,715 | 4,757 | -55 | -1.1% | 1,670,800 |
| 2024/06/06 | 4,862 | 4,865 | 4,798 | 4,812 | -2 | ±0% | 1,536,700 |
| 2024/06/05 | 4,807 | 4,814 | 4,725 | 4,814 | +27 | +0.6% | 1,357,100 |
| 2024/06/04 | 4,742 | 4,802 | 4,700 | 4,787 | -25 | -0.5% | 1,888,600 |
| 2024/06/03 | 4,850 | 4,872 | 4,812 | 4,812 | +31 | +0.6% | 1,415,700 |
| 2024/05/31 | 4,714 | 4,816 | 4,693 | 4,781 | +89 | +1.9% | 6,295,300 |
| 2024/05/30 | 4,640 | 4,705 | 4,572 | 4,692 | +8 | +0.2% | 2,310,000 |
| 2024/05/29 | 4,753 | 4,767 | 4,662 | 4,684 | -80 | -1.7% | 2,045,300 |
| 2024/05/28 | 4,773 | 4,791 | 4,749 | 4,764 | -43 | -0.9% | 1,180,500 |
| 2024/05/27 | 4,748 | 4,813 | 4,718 | 4,807 | +59 | +1.2% | 1,333,100 |
| 2024/05/24 | 4,740 | 4,756 | 4,702 | 4,748 | -39 | -0.8% | 2,377,800 |
| 2024/05/23 | 4,817 | 4,855 | 4,721 | 4,787 | -59 | -1.2% | 2,597,800 |
| 2024/05/22 | 4,995 | 5,005 | 4,840 | 4,846 | -190 | -3.8% | 3,040,300 |
| 2024/05/21 | 5,011 | 5,055 | 4,965 | 5,036 | ±0 | ±0% | 1,958,700 |
| 2024/05/20 | 4,989 | 5,076 | 4,978 | 5,036 | +29 | +0.6% | 1,828,500 |
| 2024/05/17 | 4,900 | 5,039 | 4,895 | 5,007 | +41 | +0.8% | 1,914,300 |
| 2024/05/16 | 4,893 | 4,986 | 4,836 | 4,966 | +143 | +3% | 3,057,900 |
| 2024/05/15 | 4,833 | 4,884 | 4,801 | 4,823 | +25 | +0.5% | 2,316,200 |
| 2024/05/14 | 4,955 | 4,958 | 4,687 | 4,798 | -168 | -3.4% | 5,633,700 |
| 2024/05/13 | 4,901 | 4,993 | 4,901 | 4,966 | +20 | +0.4% | 1,363,100 |
| 2024/05/10 | 4,933 | 5,007 | 4,900 | 4,946 | +22 | +0.4% | 1,646,500 |
| 2024/05/09 | 4,935 | 5,028 | 4,923 | 4,924 | -2 | ±0% | 1,118,700 |
| 2024/05/08 | 4,994 | 5,030 | 4,907 | 4,926 | -59 | -1.2% | 1,953,700 |
| 2024/05/07 | 5,145 | 5,148 | 4,943 | 4,985 | -109 | -2.1% | 2,536,200 |
| 2024/05/02 | 5,124 | 5,159 | 5,052 | 5,094 | +68 | +1.4% | 2,013,600 |
| 2024/05/01 | 5,093 | 5,110 | 5,014 | 5,026 | -24 | -0.5% | 1,680,000 |
| 2024/04/30 | 5,050 | 5,079 | 4,968 | 5,050 | +198 | +4.1% | 2,773,500 |
| 2024/04/26 | 4,887 | 4,908 | 4,726 | 4,852 | -8 | -0.2% | 4,608,300 |
| 2024/04/25 | 4,862 | 5,048 | 4,830 | 4,860 | -291 | -5.6% | 3,680,700 |
| 2024/04/24 | 5,211 | 5,376 | 5,115 | 5,151 | -34 | -0.7% | 3,109,900 |
201～
250
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 862,000円 | +1.7% | +5.0% | 2.90% | 34.60倍 | 7.46倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 370,200円 | +6.0% | +4.0% | 2.11% | 22.98倍 | 4.25倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 441,900円 | +7.7% | +206.9% | 4.44% | 59.10倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
